Browse life science companies in London, including biotechnology firms, pharmaceutical companies and leading research organisations.
Systems biology platform for brain disease drug discovery and repurposing
BRAINCURES is a computational biotechnology company applying a systems biology approach to drug discovery for brain diseases, including Alzheimer's disease, depression, epilepsy, pain and schizophrenia. Its platform maps molecular relationships between compounds, genes and diseases, drawing on its own model of the…
Single-cell omics analysis platform for precision neuroscience research
CellClar is a UK-based Community Interest Company developing an AI-assisted software platform for single-cell omics data analysis in precision medicine. Its flagship product is designed to transform complex single-cell sequencing datasets into actionable insights for researchers working on neurodegenerative diseases,…
AI drug discovery platform targeting neurological diseases
CoSyne Therapeutics is a drug discovery company applying AI and computational methods to identify and develop therapeutics for neurological diseases. The company describes its approach as polymathic AI, integrating models across biology, chemistry, and genomics to generate and prioritise drug targets. CoSyne operates…
Ex vivo haematopoietic stem cell gene therapies for rare genetic diseases
Orchard Therapeutics is a gene therapy company developing ex vivo haematopoietic stem cell therapies for rare genetic diseases, primarily severe neurometabolic and immunological disorders in children. Its platform modifies a patient's own stem cells with a functional copy of the defective gene before reinfusion. Lead…
AAV gene therapies for neurodegenerative diseases including FTD and ALS
AviadoBio is a clinical-stage gene therapy company developing AAV-based treatments for neurodegenerative diseases. Its lead programme, AVB-101, is in a Phase 1/2 trial for frontotemporal dementia caused by GRN gene mutations, delivering a functional copy of the GRN gene via intrathalamic infusion to restore…
Microbial conversion of biosolids into organic acids and nutrients
reNEW Technologies develops biological processes for recovering useful chemicals and nutrients from organic waste and sewage sludge. Its patented two-stage treatment combines fermentation and separation to produce volatile fatty acids and nutrient-rich fractions, which can be used in cleaning products, fertilisers and…
Clinical trial management, monitoring and regulatory operations
Mira Projects is a contract research organisation providing clinical trial management and operational support to pharmaceutical, biotechnology and medical device sponsors. Its services cover Phase I–IV study start-up, site selection, investigator meetings, clinical monitoring, regulatory submissions, safety reporting…
Recombinant antibodies developed using display technology platforms
Tresars is a developer and manufacturer of synthetic, non-animal-derived recombinant antibodies for life science research. Using phage, yeast, mRNA, and ribosome display technologies, the company selects and affinity-matures antibody clones against customer-specified protein targets without animal immunisation.…
CBD-based licensed medicines for chronic inflammatory pain
Ananda Pharma is an AQSE-listed UK biotechnology company developing pharmaceutical-grade cannabidiol formulations as licensed medicines for chronic inflammatory pain conditions. The company focuses on essentially THC-free CBD products manufactured to UK pharmaceutical standards, targeting conditions including…
Automated bioreactor platform for GMP cell therapy manufacturing
Aglaris is a developer of automated cell manufacturing systems for advanced therapy medicinal products. Its flagship platform integrates real-time process monitoring, single-use culture cartridges, and GMP-compliant controls to enable reproducible production of CAR-T cells, mesenchymal stem cells, and other cell types…
AI-driven neuroimaging analytics for clinical trials
Queen Square Analytics is a UCL spin-out providing advanced neuroimaging data analytics for neurological clinical trials. The company applies machine learning to MRI data for patient stratification, treatment response prediction, and imaging protocol design, with a primary focus on multiple sclerosis and…
Laboratory information management and AI-enabled sample workflow software
Cenevo is a laboratory software company providing integrated systems for scientific sample management, research records and workflow automation. Its platforms combine electronic laboratory notebooks, laboratory information management, compound and biological sample tracking, inventory control and instrument…
Inhaled antifungal therapies for serious respiratory fungal infections
Pulmocide is a late-stage biopharmaceutical company developing inhaled medicines for life-threatening respiratory fungal infections. Its lead compound opelconazole is a triazole antifungal designed for inhaled delivery to maximise pulmonary drug concentration while minimising systemic exposure and drug interactions.…
Plant-based polymer products and sustainable plastics alternatives
Candee is a UK bio-based materials brand within HOL Group, commercialising alternatives to conventional fossil-derived plastic products. Using a plant-based polymer blend formulated by an external materials partner, it engineers and supplies moulded and printed products for retail, packaging, healthcare and industrial…
CAR T cell therapies for blood cancer and autoimmune disease
Autolus Therapeutics is a London-based commercial-stage biopharma developing next-generation programmed T cell therapies. Its lead product AUCATZYL (obecabtagene autoleucel) received FDA approval in November 2024 and MHRA conditional marketing authorisation in 2025 for relapsed or refractory B-cell acute lymphoblastic…
FDA-approved AI blood test for diabetic kidney disease risk
Renalytix is an artificial intelligence-enabled in vitro diagnostics company focused on the clinical management of chronic kidney disease. Its blood-based test combines biomarker analysis with machine learning to generate a five-year kidney function decline risk score in adults with type 2 diabetes and CKD stages 1 to…
AI-driven liquid biopsy platform for early cancer biomarker discovery
BioMavericks is an early-stage biotechnology company developing an AI-driven liquid biopsy platform for the early detection of cancer. Its lead product targets the discovery and validation of blood-based biomarkers for early-stage pancreatic cancer diagnostics, integrating molecular cell biology, multi-omics data…
Compostable polymer materials produced through microbial fermentation
Shellworks is a materials biotechnology company that develops and manufactures a bio-based, home-compostable polymer produced through microbial fermentation of plant-derived waste feedstocks. The polymer is formulated to replicate the functional properties of conventional plastic while biodegrading fully in home…
AI-driven digital modelling platform for pharmaceutical process development
PolyModels Hub is a software company developing a digital platform that uses physics-based and AI-driven models to help pharmaceutical process scientists design, simulate and optimise manufacturing processes. The platform replaces traditional experiment-heavy development workflows with predictive digital modelling,…
Programmable synthetic organelle tools for protein expression and purification
Ailurus is a synthetic biology company that develops programmable biological systems and sells them as research tools to life science customers. Its current product uses synthetic membraneless organelles engineered through genetic code to streamline protein expression and purification in bacterial hosts, reducing…